A Prospective Munti-center Study on VANGUARD™ PS Total Knee Replacement System

NCT01906177 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-06-26

No results posted yet for this study

Summary

The primary objectives of this pilot clinical study include:

* Evaluate clinical outcomes and quality of life on patients who received Vanguard PS Total Knee in Korean population
* Evaluate safety of Vanguard PS Total Knee in Korean population

Conditions

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Young Joon Choi, PHD · Gangneung Asan Hospital

  • Jong Keun Seon, PHD · Chonnam National University Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01906177 on ClinicalTrials.gov